Respiratory Medicine
Volume 105, Issue 2 , Pages 259-265 , February 2011

Three-year dispensing patterns with long-acting inhaled drugs in COPD: A database analysis

  • Fernie Penning-van Beest

      Affiliations

    • PHARMO Institute, PO Box 85222, 3508 AE Utrecht, Utrecht, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 302345 162; fax: +31 302345 568.
    • ,
  • Myrthe van Herk-Sukel

      Affiliations

    • PHARMO Institute, PO Box 85222, 3508 AE Utrecht, Utrecht, The Netherlands
    • ,
  • Rupert Gale

      Affiliations

    • Novartis Horsham Research Centre, UK
    • ,
  • Jan-Willem Lammers

      Affiliations

    • Department of Respiratory Medicine, University Medical Centre Utrecht, The Netherlands
    • ,
  • Ron Herings

      Affiliations

    • PHARMO Institute, PO Box 85222, 3508 AE Utrecht, Utrecht, The Netherlands
    • Department of Health Policy & Management, Erasmus University Medical Centre, Rotterdam, The Netherlands

Received 15 March 2010 ,Accepted 9 July 2010.

References 

  1. Chronic Obstructive Pulmonary Disease (COPD) . Fact sheet No 315. [online]. [accessed 19.06.09] http://www.who.int/mediacentre/factsheets/fs315/en/index.htmlMay 2008;
  2. Global Initiative for Chronic Obstructive Lung Disease (GOLD) . Global strategy for the diagnosis, management, and prevention of COPD. [online]. [accessed 19.06.09] http://www.goldcopd.com/Guidelineitem.asp?l1=2&l2=1&intId=9892008;
  3. Restrepo RD, Alvarez MT, Wittnebel LD, Sorenson H, Wettstein R, Vines DL, et al. Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis. 2008;3(3):371–384
  4. Foster JA, Yawn BP, Maziar A, Jenkins T, Rennard SI, Casebeer L. Enhancing COPD management in primary care settings. Med Gen Med. 2007;9(3):24
  5. Glaab T, Banik N, Rutschmann OT, Wencker M. National survey of guideline-compliant COPD management among pneumologists and primary care physicians. Int J Chron Obstruct Pulmon Dis. 2006 Aug;3(3):141–148
  6. Breekveldt-Postma NS, Koerselman J, Erkens JA, Lammers JW, Herings RM. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD. Respir Med. 2007 Jul;101(7):1398–1405
  7. Cramer JA, Bradley-Kennedy C, Scalera A. Treatment persistence and compliance with medications for chronic obstructive pulmonary disease. Can Respir J. 2007 Jan–Feb;14(1):25–29
  8. Catalan VS, LeLorier J. Predictors of long-term persistence on statins in a subsidized clinical population. Value in Health. 2000;3(6):417–426
  9. de Melo MN, Ernst P, Suissa S. Inhaled corticosteroids and the risk of a first exacerbation in COPD patients. Eur Respir J. 2004 May;23(5):692–697
  10. Breekveldt-Postma NS, Gerrits CM, Lammers JW, Raaijmakers JA, Herings RM. Persistence with inhaled corticosteroid therapy in daily practice. Respir Med. 2004 Aug;98(8):752–759
  11. Haupt D, Krigsman K, Nilsson JL. Medication persistence among patients with asthma/COPD drugs. Pharm World Sci. 2008 Oct;30(5):509–514
  12. Krigsman K, Moen J, Nilsson JL, Ring L. Refill adherence by the elderly for asthma/chronic obstructive pulmonary disease drugs dispensed over a 10-year period. J Clin Pharm Ther. 2007 Dec;32(6):603–611
  13. Blais L, Bourbeau J, Sheehy O, LeLorier J. Inhaled corticosteroids in COPD: determinants of use and trends in patient persistence with treatment. Can Respir J. 2004 Jan–Feb;11(1):27–32
  14. Breekveldt-Postma NS, Penning-van Beest FJ, Siiskonen SJ, Koerselman J, Klungel OH, Falvey H, et al. Effect of persistent use of antihypertensives on blood pressure goal attainment. Curr Med Res Opin. 2008 Apr;24(4):1025–1031
  15. Penning-van Beest FJ, Termorshuizen F, Goettsch WG, Klungel OH, Kastelein JJ, Herings RM. Adherence to evidence-based statin guidelines reduces the risk of hospitalizations for acute myocardial infarction by 40%: a cohort study. Eur Heart J. 2007 Jan;28(2):154–159
  16. Penning-van Beest FJA, van der Bij S, Erkens JA, Kessabi S, Groot M, Herings RM. Effect on non-persistent use of oral glucose-lowering drugs on HbA1c goal attainment. Curr Med Res Opin. 2008 July;24(9):2523–2529
  17. Siris ES, Selby PL, Saag KG, Borgstrom F, Herings RM, Silverman SL. Impact of osteoporosis treatment adherence on fracture rates in North America and Europe. Am J Med. 2009 Feb;122(Suppl. 2):S3–S13
  18. George J, Kong DC, Thoman R, Stewart K. Factors associated with medication nonadherence in patients with COPD. Chest. 2005 Nov;128(5):3198–3204

PII: S0954-6111(10)00326-4

doi: 10.1016/j.rmed.2010.07.007

Respiratory Medicine
Volume 105, Issue 2 , Pages 259-265 , February 2011

Article Tools

* Image Usage & Resolution